Data gathered: September 7
Alternative Data for Dexcom
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 232 | Sign up | Sign up | Sign up |
| Sentiment | 88 | Sign up | Sign up | Sign up |
| Webpage traffic | 2,609,000 | Sign up | Sign up | Sign up |
| Employee Rating | 76 | Sign up | Sign up | Sign up |
| Google Trends | 66 | Sign up | Sign up | Sign up |
| Patents | 804 | Sign up | Sign up | Sign up |
| App Downloads | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 9,338 | Sign up | Sign up | Sign up |
| Facebook Followers | 192,689 | Sign up | Sign up | Sign up |
| Instagram Followers | 171,599 | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 28 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 9,798 | Sign up | Sign up | Sign up |
| Twitter Followers | 8,975 | Sign up | Sign up | Sign up |
| Twitter Mentions | 30 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 37,900 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | 32 | Sign up | Sign up | Sign up |
| Business Outlook | 75 | Sign up | Sign up | Sign up |
| Linkedin Employees | 7,032 | Sign up | Sign up | Sign up |
About Dexcom
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
| Price | $68.61 |
| Target Price | Sign up |
| Volume | 3,530,000 |
| Market Cap | $27.7B |
| Year Range | $64 - $140.45 |
| Dividend Yield | 0% |
| PE Ratio | 42.88 |
| Industry | Medical Devices |
In the news
DXCM DEADLINE REMINDER: DexCom, Inc. Investors who Lost Money are Reminded to Contact BFA Law before Upcoming Securities Litigation Deadline (Nasdaq:DXCM)September 7 - GlobeNewswire |
|
DEADLINE ALERT for STLA, SPIR, OFIX, and DXCM: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of ShareholdersSeptember 6 - GlobeNewswire |
|
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud LawsuitSeptember 6 - Finnhub |
|
Investors who lost money on DexCom, Inc.(DXCM) should contact Levi & Korsinsky about pending Class Action - DXCMSeptember 5 - Finnhub |
|
DXCM Lawsuit Reminder: Robbins LLP Encourages DexCom Inc. Stockholders to Seek Counsel for Class Action LawsuitSeptember 5 - GlobeNewswire |
|
DEADLINE ALERT for SPIR, DXCM, OFIX, STM: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of ShareholdersSeptember 5 - GlobeNewswire |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 1B | 710M | 627M | 144M | 0 | 0.430 |
| Q1 '24 | 916M | 678M | 562M | 146M | 190M | 0.320 |
| Q4 '23 | 1.03B | 696M | 657M | 256M | 261M | 0.500 |
| Q3 '23 | 970M | 638M | 623M | 121M | 247M | 0.500 |
| Q2 '23 | 865M | 624M | 546M | 116M | 167M | 0.340 |
Insider Transactions View All
| Brown Michael Jon filed to sell 65,636 shares at $70. September 3 '24 |
| Brown Michael Jon filed to sell 66,249 shares at $69.6. August 1 '24 |
| Brown Michael Jon filed to sell 66,901 shares at $114.3. June 28 '24 |
| FOLETTA MARK G filed to sell 56,398 shares at $117.2. June 20 '24 |
| FOLETTA MARK G filed to sell 56,697 shares at $116.7. June 20 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$81.6 0% | 52 |
 |
Edwards LifesciencesEW |
$66.81 0% | 40 |
 |
Intuitive SurgicalISRG |
$471.82 0% | 52 |
 |
MedtronicMDT |
$89.89 0% | 42 |
 |
StrykerSYK |
$358.92 0% | 71 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Sell | $1K - $15K |
Read more about Dexcom (DXCM) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, app downloads, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Dexcom?
The Market Cap of Dexcom is $27.7B.
What is Dexcom's PE Ratio?
As of today, Dexcom's PE (Price to Earnings) ratio is 42.88.
What is the current stock price of Dexcom?
Currently, the price of one share of Dexcom stock is $68.61.
How can I analyze the DXCM stock price chart for investment decisions?
The DXCM stock price chart above provides a comprehensive visual representation of Dexcom's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Dexcom shares. Our platform offers an up-to-date DXCM stock price chart, along with technical data analysis and alternative data insights.
Does DXCM offer dividends to its shareholders?
As of our latest update, Dexcom (DXCM) does not offer dividends to its shareholders. Investors interested in Dexcom should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Dexcom?
Some of the similar stocks of Dexcom are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.